Latest Updates

Promotions
Promotions
New Data
New Data
Lab Schedule
Lab Schedule
Bug Fixes
Bug Fixes
Product Updates
Product Updates
Announcements
Announcements
Product Updates
May 19, 2025

CHOP Model Just Got Smarter – Improved CHOP Predictions with More Data and Updated Metrics

ImpriMed’s updated CHOP response predictions now include patient-specific progression-free survival insights and new real-world performance metrics—c-index and hazard ratio—to better support your clinical decisions.

Read More →
Product Updates
May 19, 2025

Updated Sample Requirements

After careful analysis, we are updating our protocol to require 3 fine needle aspiration (FNA) or biopsy tubes for certain services. This change is designed to decrease resubmission rates and improve the efficiency of our ordering process.

Read More →
Product Updates
May 16, 2023

ImpriMed Launches Multidrug Sensitivity Genotyping (MDR1) for Dogs

We are thrilled to announce that our Multidrug Sensitivity Genotyping (MDR1) is now available to provide you actionable information about the sensitivity of your canine patients to many commonly-used drugs.

Read More →
Product Updates
May 16, 2023

Dexamethasone and Mechlorethamine are now included in the AI-driven Single Drug Response Models

Thanks to your contributions in providing post-ImpriMed patient medical records, we used machine learning (ML) to develop single drug response models for Dexamethasone and Mechlorethamine.

Read More →
Product Updates
May 16, 2023

Announcing ImpriMed’s Next Generation of AI Models for CHOP Therapy Outcome Prediction (v2)

ImpriMed is thrilled to announce that, on November 1st 2022, we will be upgrading the CHOP therapy section of our Personalized Prediction Profile with more powerful artificial intelligence (AI) models and an easy-to-read report format that provides faster access to critical information.

Read More →
Product Updates
May 16, 2023

ImpriMed releases a new generation of artificial intelligence models

On June 27th, ImpriMed's Data Science team released a new generation of AI models for canine lymphoma with improved predictive performance. The models, which predict the likelihood of a positive clinical response to 10 different chemotherapy drugs, were optimized to give higher sensitivity and...

Read More →